DUBLIN--(BUSINESS WIRE)--Dublin - Research and Markets (http://www.researchandmarkets.com/research/nfjntv/turkey_pharmaceuti) has announced the addition of the "Turkey Pharmaceuticals and Healthcare Report Q3 2012" report to their offering.
BMI View:
Before 2010, Turkey's pharmaceutical market growth was rapidly driven by modernisation, growing investment and improving awareness about healthcare. Since 2009, Turkey's pharmaceutical industry has been beset by government-imposed price controls and the worsening economic environment has moderated some of the more optimistic outlooks for this market. The drug market in 2012 will be defined by the price cutting and public discount decree announced in November 2011, though we note the more favourable concessions agreed in December and January. Headline
Key Trends And Developments:
- In March 2012, it emerged that Novartis will build a new plant in Turkey, company board member Alexandre F. Jetzer-Chung has told Turkish Minister of Industry Nihat Erg?n.
- In the 2012 PhRMA Special 301 submission, Turkey makes the top of the entire global list with the status as the priority foreign country.
- In January 2012, it emerged that Abdi Ibrahim is set to expand to new markets by establishing operations and partnerships with local firms in the Middle East, North Africa and Central Asia.
Publication Overview:
Business Monitor International's Turkey Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on Turkey's pharmaceuticals and healthcare industry.
Key Topics Covered:
- Executive Summary
- SWOT Analysis
- Pharmaceuticals & Healthcare Risk/Reward Ratings
- Turkey - Market Summary
- Industry Developments
- Industry Forecast Scenario
- Competitive Landscape
- Company Profiles
- Demographic Outlook
- Glossary
- BMI Methodology
Companies Mentioned:
- Abdi ?brahim
- Eczaciba?i Pharmaceuticals
- Sanovel Pharmaceuticals
- Deva (EastPharma)
- Mustafa Nevzat Ilac Sanayi (MN) Pharmaceuticals
- Novartis
- Pfizer
- Sanofi
- GlaxoSmithKline
- Roche
- AstraZeneca
- Bayer
- Merck & Co
For more information, including full table of contents, please visit http://www.researchandmarkets.com/research/nfjntv/turkey_pharmaceuti